Real-World Experience with Carbidopa-Levodopa Extended-Release Capsules (Rytary^®): Results of a Nationwide Dose Conversion Survey

Figure 3

Likelihood of switching to CD-LD ER: multiple OFFs and no dyskinesia per CD-LD IR dosing frequency.